Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |